Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Tissue Regenerative Therapy Companies, Market Growth and Value Chain Analysis

Date : 13 February 2026

Latest Updates of Companies in the Tissue Regenerative Therapy Market with Key Development

Tissue Regenerative Therapy Market Key Players

Company Overview

Company Headquarters Latest Update
Novartis AG Switzerland In October 2025, Novartis presents momentous immunology developments in ACR congress with novel data in challenging autoimmune diseases.
Gilead Sciences, Inc. United States Gilead Sciences, Inc. is significantly focused on expanding its cell therapy portfolio and investing in In Vivo therapeutics, which are thoroughly related to the advancement in tissue regeneration and, precisely, CAR-T in solid tumors.
Smith & Nephew plc United States In September 2025, Smith Nephew is a portfolio medical technology business focused on the repair, regeneration, and replacement of soft and hard tissue.
Medtronic plc United States Medtronic explores the next frontier in medical care: regenerative medicine.
Stryker Corporation United States Stryker unveils novel intracranial base catheter to streamline neurovascular admission and therapy delivery.
Integra LifeSciences Corporation United States Integra LifeSciences Corporation is focusing heavily on rehabilitating its supply chain and progressing its portfolio of tissue regenerative therapies.

Value Chain Analysis: Tissue Regenerative Therapy Market

R&D:

  • Major R&D processes include cell source engineering and manipulation, biomaterials and scaffold fabrication, bioactive factor discovery and delivery, genetic engineering and precision medicine, bioprocess and translational research
  • Key Players: Pfizer and Novartis

Manufacturing Processes:

  • Manufacturing processes for tissue regeneration therapies follow a structured workflow that integrates biological components with engineering processes to create functional substitutes for injured tissues
  • Key Players: MiMedx Group and Integra LifeSciences

Patient Services:

  • Tissue regeneration therapy includes an inclusive suite of patient solutions aimed at repairing, replacing, or regenerating damaged cells, tissues, and organs.
  • Key Players: Vericel Corporation and Organogenesis Inc.

Market Growth

The global tissue regenerative therapy market size was estimated at USD 15.04 billion in 2025 and is predicted to increase from USD 16.85 billion in 2026 to approximately USD 46.88 billion by 2035, expanding at a CAGR of 12.04% from 2026 to 2035.

Tissue Regenerative Therapy Market Trends and Growth (2026)

Recent Developments in the Tissue Regenerative Therapy Market

  • In December 2025, Cipla announced the launch of Ciplostem, an allogeneic mesenchymal stromal cell therapy for Knee Osteoarthritis, approved by the Drug Controller General of India (DCGI). The therapy has been developed by Semeiotics Research and targets Grade II and Grade III Knee OA.
  • In August 2025, Adia Nutrition Inc. announced the launch of its second nationwide television campaign, spotlighting the regenerative stem cell treatments available at its Winter Park, Florida, clinic.

Bring every Tissue Regenerative Therapy Market Data together under one roof - Access the Dashboard

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales